MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jakubík, J.
Right arrow Articles by Haga, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jakubík, J.
Right arrow Articles by Haga, T.

Vol. 54, Issue 5, 899-906, November 1998

Effects of an Agonist, Allosteric Modulator, and Antagonist on Guanosine-gamma -[35S]thiotriphosphate Binding to Liposomes with Varying Muscarinic Receptor/Go Protein Stoichiometry

Jan Jakubík,1 Tatsuya Haga, and Stanislav Tucek

Institute of Physiology, Academy of Sciences of the Czech Republic, 14220 Prague, Czechia (J.J., S.T.), and Department of Neurochemistry, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan (T.H.)

We investigated whether alcuronium, an allosteric modulator of muscarinic acetylcholine receptors, can induce receptor-mediated activation of Go proteins in liposomal membranes incorporating purified M2 receptors and Go proteins and whether its action is affected by the receptor/Go protein (R/Go) ratio. The binding of guanosine-gamma -[35S]thiotriphosphate ([35S]GTPgamma S) served as the indicator of G protein activation. It was stimulated by empty receptors at high receptor densities, and the dose-response curve was shifted to the left by the agonist carbachol and to the right by the antagonist atropine. At an R/Go ratio of 300:100, the rate of [35S]GTPgamma S binding was the same in the presence or absence of 0.1 mM carbachol. Alcuronium increased the binding of [35S]GTPgamma S at R/Go ratios of <3:100 and diminished it at R/Go ratios of >10:100, similar to previous observations on intact cells expressing muscarinic receptors at different densities. The apparent biphasicity of alcuronium action indicates that the allosteric modulator has at least two effects on muscarinic receptor/G protein interaction but its mechanistic basis is unclear. The "active state" of muscarinic receptors induced by alcuronium probably is different from that induced by carbachol. Changes in the densities of receptors and Go proteins had little effect on the kinetics of [35S]GTPgamma S binding and on receptor affinity for carbachol, provided the R/Go ratio was kept constant. This suggests that the receptors and G proteins are located in microdomains in which their concentrations remain constant, despite variations in the amounts of lipidic membranes in the system.

Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
E. Machova, J. Jakubik, E. E. El-Fakahany, and V. Dolezal
Wash-Resistantly Bound Xanomeline Inhibits Acetylcholine Release by Persistent Activation of Presynaptic M2 and M4 Muscarinic Receptors in Rat Brain
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 316 - 323.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. Michal, E. E. El-Fakahany, and V. Dolezal
Muscarinic M2 Receptors Directly Activate Gq/11 and Gs G-Proteins
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 607 - 614.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. J. Langmead, V. A. H. Fry, I. T. Forbes, C. L. Branch, A. Christopoulos, M. D. Wood, and H. J. Herdon
Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist
Mol. Pharmacol., January 1, 2006; 69(1): 236 - 246.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. T. May, Y. Lin, P. M. Sexton, and A. Christopoulos
Regulation of M2 Muscarinic Acetylcholine Receptor Expression and Signaling by Prolonged Exposure to Allosteric Modulators
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 382 - 390.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Jakubik, S. Tucek, and E. E. El-Fakahany
Role of Receptor Protein and Membrane Lipids in Xanomeline Wash-Resistant Binding to Muscarinic M1 Receptors
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 105 - 110.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Cordeaux, S. A. Nickolls, L. A. Flood, S. G. Graber, and P. G. Strange
Agonist Regulation of D2 Dopamine Receptor/G Protein Interaction. EVIDENCE FOR AGONIST SELECTION OF G PROTEIN SUBTYPE
J. Biol. Chem., July 27, 2001; 276(31): 28667 - 28675.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics